Global Opioids Drugs Market – Industry Analysis and Forecast (2019-2026) –By Products, Application, and Region.

Global Opioids Drugs Market – Industry Analysis and Forecast (2019-2026) –By Products, Application, and Region.

Market Scenario

Global opioids drugs market was valued US$ 22.85 Bn in 2019 and is expected to reach US$ 32.6 Bn by 2026, at a CAGR of 4.54 % during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Opioids are narcotic drugs act on the nervous system and used to reduce pain, but can also have serious risks and side effects. Side Effects of Opioids: • Nausea & vomiting • Abdominal distention & bloating • Constipation • Liver damage • Brain damage due to hypoxia, resulting from respiratory depression • Development of tolerance Opioids are mainly used in cancer pain management and end-stage diseases in which painkilling care is required. The rising prevalence of cancer, high demand for pain therapeutics in the treatment of chronic pain, regulatory approvals & launches of innovative drug formulations, and increasing approval rate of abuse-deterrent formulations of opioid drugs are major driving factors of the global opioids drugs market. Extensive misuse of opioids, the growing incidence of death related to opioid overdose, and rising number of lawsuits against opioid manufacturers are hindering the growth of the market. Oxycodone holds the largest market share in terms of product, owing to the used to help relieve moderate to severe pain. It works in the brain to change how your body feels and responds to pain. Oxycodone may cause side effects such as dry mouth, stomach pain, drowsiness, flushing, headache, and mood changes. Anesthesia is the majorly used application in the opioids drugs market. A major benefit of opioid anesthesia is the cardiovascular stability obtained during orientation and throughout the operation, even in patients with severely impaired cardiac function. According to health experts, the risk of complications during anesthesia are increased due to the rising rate of smoking, high blood pressure, diabetes, obstructive sleep arena and lung related to heart, and drug allergies or the past reactions related to anesthesia. North America is the leading opioids drugs market and accounting for nearly 65% revenue share, followed by Europe. Due to growing painkilling care facilities, reformed regulations for prescription of opioids, and extensive focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF) are expected to drive the growth of the opioids market in North America, followed by Europe. The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

The Scope of Global Opioids Drugs Market:

Global Opioids Drugs Market, by Products:

• Buprenorphine • Fentanyl • Hydrocodone • Morphine • Oxycodone • Tramadol • Other products

Global Opioids Drugs Market, by Application:

• Anesthesia • Pain relief • Cough suppression • Diarrhea suppression • Deaddiction

Global Opioids Drugs Market, by Region:

• North America • Europe • Asia-Pacific • South America • Middle East & Africa

Key Player Operating In the Global Opioids Drugs Market:

• Acura Pharmaceuticals Inc. • Allergan Plc • Apotex Inc. • Assertio Therapeutics Inc. (Depomed Inc.) • Biodelivery Sciences International Inc. • Cipher Pharmaceuticals Inc. • Collegium Pharmaceutical Inc. • Daiichi Sankyo Inc. • Egalet Corp. • Endo International Plc • Hikma Pharmaceuticals Plc • Indivior Plc • Insys Therapeutics Inc. • Johnson & Johnson • Kempharm Inc. • Lannett Co. Inc. • Lupin Ltd. • Mallinckrodt • Mylan Nv • Orexo Ab • Pernix Therapeutics • Pfizer Inc. • Purdue Pharma Lp • Sun Pharmaceutical Industries Ltd. (Sun Pharma) • Teva Pharmaceutical Industries Ltd.

Table of Contents

Global opioids drugs market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Opioids Drugs Market Size, by Market Value (US$ Bn) and Volume(Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Opioids Drugs Market Analysis and Forecast 6.1. Global Opioids Drugs Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Opioids Drugs Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Opioids Drugs Market Value Share Analysis, by Product 7.4. Global Opioids Drugs Market Size (US$ Bn) Forecast, by Product 7.5. Global Opioids Drugs Market Analysis, by Product 7.6. Global Opioids Drugs Market Attractiveness Analysis, by Product 8. Global Opioids Drugs Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Opioids Drugs Market Value Share Analysis, by Application 8.4. Global Opioids Drugs Market Size (US$ Bn) Forecast, by Application 8.5. Global Opioids Drugs Market Analysis, by Application 8.6. Global Opioids Drugs Market Attractiveness Analysis, by Application 9. Global Opioids Drugs Market Analysis, by Region 9.1. Global Opioids Drugs Market Value Share Analysis, by Region 9.2. Global Opioids Drugs Market Size (US$ Bn) Forecast, by Region 9.3. Global Opioids Drugs Market Attractiveness Analysis, by Region 10. North America Opioids Drugs Market Analysis 10.1. Key Findings 10.2. North America Opioids Drugs Market Overview 10.3. North America Opioids Drugs Market Value Share Analysis, by Product 10.4. North America Opioids Drugs Market Forecast, by Product 10.4.1. Buprenorphine 10.4.2. Fentanyl 10.4.3. Hydrocodone 10.4.4. Morphine 10.4.5. Oxycodone 10.4.6. Tramadol 10.4.7. Other 10.5. North America Opioids Drugs Market Value Share Analysis, by Application 10.6. North America Opioids Drugs Market Forecast, by Application 10.6.1. Anesthesia 10.6.2. Pain relief 10.6.3. Cough suppression 10.6.4. Diarrhea suppression 10.6.5. Deaddiction 10.7. North America Opioids Drugs Market Value Share Analysis, by Country 10.8. North America Opioids Drugs Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Opioids Drugs Market Analysis, by Country 10.10. U.S. Opioids Drugs Market Forecast, by Product 10.10.1. Buprenorphine 10.10.2. Fentanyl 10.10.3. Hydrocodone 10.10.4. Morphine 10.10.5. Oxycodone 10.10.6. Tramadol 10.10.7. Other 10.11. U.S. Opioids Drugs Market Forecast, by Application 10.11.1. Anesthesia 10.11.2. Pain relief 10.11.3. Cough suppression 10.11.4. Diarrhea suppression 10.11.5. Deaddiction 10.12. Canada Opioids Drugs Market Forecast, by Product 10.12.1. Buprenorphine 10.12.2. Fentanyl 10.12.3. Hydrocodone 10.12.4. Morphine 10.12.5. Oxycodone 10.12.6. Tramadol 10.12.7. Other 10.13. Canada Opioids Drugs Market Forecast, by Application 10.13.1. Anesthesia 10.13.2. Pain relief 10.13.3. Cough suppression 10.13.4. Diarrhea suppression 10.13.5. Deaddiction 10.14. North America Opioids Drugs Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Opioids Drugs Market Analysis 11.1. Key Findings 11.2. Europe Opioids Drugs Market Overview 11.3. Europe Opioids Drugs Market Value Share Analysis, by Product 11.4. Europe Opioids Drugs Market Forecast, by Product 11.4.1. Buprenorphine 11.4.2. Fentanyl 11.4.3. Hydrocodone 11.4.4. Morphine 11.4.5. Oxycodone 11.4.6. Tramadol 11.4.7. Other 11.5. Europe Opioids Drugs Market Value Share Analysis, by Application 11.6. Europe Opioids Drugs Market Forecast, by Application 11.6.1. Anesthesia 11.6.2. Pain relief 11.6.3. Cough suppression 11.6.4. Diarrhea suppression 11.6.5. Deaddiction 11.7. Europe Opioids Drugs Market Value Share Analysis, by Country 11.8. Europe Opioids Drugs Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Opioids Drugs Market Analysis, by Country 11.10. Germany Opioids Drugs Market Forecast, by Product 11.10.1. Buprenorphine 11.10.2. Fentanyl 11.10.3. Hydrocodone 11.10.4. Morphine 11.10.5. Oxycodone 11.10.6. Tramadol 11.10.7. Other 11.11. Germany Opioids Drugs Market Forecast, by Application 11.11.1. Anesthesia 11.11.2. Pain relief 11.11.3. Cough suppression 11.11.4. Diarrhea suppression 11.11.5. Deaddiction 11.12. U.K. Opioids Drugs Market Forecast, by Product 11.12.1. Buprenorphine 11.12.2. Fentanyl 11.12.3. Hydrocodone 11.12.4. Morphine 11.12.5. Oxycodone 11.12.6. Tramadol 11.12.7. Other 11.13. U.K. Opioids Drugs Market Forecast, by Application 11.13.1. Anesthesia 11.13.2. Pain relief 11.13.3. Cough suppression 11.13.4. Diarrhea suppression 11.13.5. Deaddiction 11.14. France Opioids Drugs Market Forecast, by Product 11.14.1. Buprenorphine 11.14.2. Fentanyl 11.14.3. Hydrocodone 11.14.4. Morphine 11.14.5. Oxycodone 11.14.6. Tramadol 11.14.7. Other 11.15. France Opioids Drugs Market Forecast, by Application 11.15.1. Anesthesia 11.15.2. Pain relief 11.15.3. Cough suppression 11.15.4. Diarrhea suppression 11.15.5. Deaddiction 11.16. Italy Opioids Drugs Market Forecast, by Product 11.16.1. Buprenorphine 11.16.2. Fentanyl 11.16.3. Hydrocodone 11.16.4. Morphine 11.16.5. Oxycodone 11.16.6. Tramadol 11.16.7. Other 11.17. Italy Opioids Drugs Market Forecast, by Application 11.17.1. Anesthesia 11.17.2. Pain relief 11.17.3. Cough suppression 11.17.4. Diarrhea suppression 11.17.5. Deaddiction 11.18. Spain Opioids Drugs Market Forecast, by Product 11.18.1. Buprenorphine 11.18.2. Fentanyl 11.18.3. Hydrocodone 11.18.4. Morphine 11.18.5. Oxycodone 11.18.6. Tramadol 11.18.7. Other 11.19. Spain Opioids Drugs Market Forecast, by Application 11.19.1. Anesthesia 11.19.2. Pain relief 11.19.3. Cough suppression 11.19.4. Diarrhea suppression 11.19.5. Deaddiction 11.20. Rest of Europe Opioids Drugs Market Forecast, by Product 11.20.1. Buprenorphine 11.20.2. Fentanyl 11.20.3. Hydrocodone 11.20.4. Morphine 11.20.5. Oxycodone 11.20.6. Tramadol 11.20.7. Other 11.21. Rest Of Europe Opioids Drugs Market Forecast, by Application 11.21.1. Anesthesia 11.21.2. Pain relief 11.21.3. Cough suppression 11.21.4. Diarrhea suppression 11.21.5. Deaddiction 11.22. Europe Opioids Drugs Market Attractiveness Analysis 11.22.1. By Product 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Opioids Drugs Market Analysis 12.1. Key Findings 12.2. Asia Pacific Opioids Drugs Market Overview 12.3. Asia Pacific Opioids Drugs Market Value Share Analysis, by Product 12.4. Asia Pacific Opioids Drugs Market Forecast, by Product 12.4.1. Buprenorphine 12.4.2. Fentanyl 12.4.3. Hydrocodone 12.4.4. Morphine 12.4.5. Oxycodone 12.4.6. Tramadol 12.4.7. Other 12.5. Asia Pacific Opioids Drugs Market Value Share Analysis, by Application 12.6. Asia Pacific Opioids Drugs Market Forecast, by Application 12.6.1. Anesthesia 12.6.2. Pain relief 12.6.3. Cough suppression 12.6.4. Diarrhea suppression 12.6.5. Deaddiction 12.7. Asia Pacific Opioids Drugs Market Value Share Analysis, by Country 12.8. Asia Pacific Opioids Drugs Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Opioids Drugs Market Analysis, by Country 12.10. China Opioids Drugs Market Forecast, by Product 12.10.1. Buprenorphine 12.10.2. Fentanyl 12.10.3. Hydrocodone 12.10.4. Morphine 12.10.5. Oxycodone 12.10.6. Tramadol 12.10.7. Other 12.11. China Opioids Drugs Market Forecast, by Application 12.11.1. Anesthesia 12.11.2. Pain relief 12.11.3. Cough suppression 12.11.4. Diarrhea suppression 12.11.5. Deaddiction 12.12. India Opioids Drugs Market Forecast, by Product 12.12.1. Buprenorphine 12.12.2. Fentanyl 12.12.3. Hydrocodone 12.12.4. Morphine 12.12.5. Oxycodone 12.12.6. Tramadol 12.12.7. Other 12.13. India Opioids Drugs Market Forecast, by Application 12.13.1. Anesthesia 12.13.2. Pain relief 12.13.3. Cough suppression 12.13.4. Diarrhea suppression 12.13.5. Deaddiction 12.14. Japan Opioids Drugs Market Forecast, by Product 12.14.1. Buprenorphine 12.14.2. Fentanyl 12.14.3. Hydrocodone 12.14.4. Morphine 12.14.5. Oxycodone 12.14.6. Tramadol 12.14.7. Other 12.15. Japan Opioids Drugs Market Forecast, by Application 12.15.1. Anesthesia 12.15.2. Pain relief 12.15.3. Cough suppression 12.15.4. Diarrhea suppression 12.15.5. Deaddiction 12.16. ASEAN Opioids Drugs Market Forecast, by Product 12.16.1. Buprenorphine 12.16.2. Fentanyl 12.16.3. Hydrocodone 12.16.4. Morphine 12.16.5. Oxycodone 12.16.6. Tramadol 12.16.7. Other 12.17. ASEAN Opioids Drugs Market Forecast, by Application 12.17.1. Anesthesia 12.17.2. Pain relief 12.17.3. Cough suppression 12.17.4. Diarrhea suppression 12.17.5. Deaddiction 12.18. Rest of Asia Pacific Opioids Drugs Market Forecast, by Product 12.18.1. Buprenorphine 12.18.2. Fentanyl 12.18.3. Hydrocodone 12.18.4. Morphine 12.18.5. Oxycodone 12.18.6. Tramadol 12.18.7. Other 12.19. Rest of Asia Pacific Opioids Drugs Market Forecast, by Application 12.19.1. Anesthesia 12.19.2. Pain relief 12.19.3. Cough suppression 12.19.4. Diarrhea suppression 12.19.5. Deaddiction 12.20. Asia Pacific Opioids Drugs Market Attractiveness Analysis 12.20.1. By Product 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Opioids Drugs Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Opioids Drugs Market Overview 13.3. Middle East & Africa Opioids Drugs Market Value Share Analysis, by Product 13.4. Middle East & Africa Opioids Drugs Market Forecast, by Product 13.4.1. Buprenorphine 13.4.2. Fentanyl 13.4.3. Hydrocodone 13.4.4. Morphine 13.4.5. Oxycodone 13.4.6. Tramadol 13.4.7. Other 13.5. Middle East & Africa Opioids Drugs Market Value Share Analysis, by Application 13.6. Middle East & Africa Opioids Drugs Market Forecast, by Application 13.6.1. Anesthesia 13.6.2. Pain relief 13.6.3. Cough suppression 13.6.4. Diarrhea suppression 13.6.5. Deaddiction 13.7. Middle East & Africa Opioids Drugs Market Value Share Analysis, by Country 13.8. Middle East & Africa Opioids Drugs Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Opioids Drugs Market Analysis, by Country 13.10. GCC Opioids Drugs Market Forecast, by Product 13.10.1. Buprenorphine 13.10.2. Fentanyl 13.10.3. Hydrocodone 13.10.4. Morphine 13.10.5. Oxycodone 13.10.6. Tramadol 13.10.7. Other 13.11. GCC Opioids Drugs Market Forecast, by Application 13.11.1. Anesthesia 13.11.2. Pain relief 13.11.3. Cough suppression 13.11.4. Diarrhea suppression 13.11.5. Deaddiction 13.12. South Africa Opioids Drugs Market Forecast, by Product 13.12.1. Buprenorphine 13.12.2. Fentanyl 13.12.3. Hydrocodone 13.12.4. Morphine 13.12.5. Oxycodone 13.12.6. Tramadol 13.12.7. Other 13.13. South Africa Opioids Drugs Market Forecast, by Application 13.13.1. Anesthesia 13.13.2. Pain relief 13.13.3. Cough suppression 13.13.4. Diarrhea suppression 13.13.5. Deaddiction 13.14. Rest of Middle East & Africa Opioids Drugs Market Forecast, by Product 13.14.1. Buprenorphine 13.14.2. Fentanyl 13.14.3. Hydrocodone 13.14.4. Morphine 13.14.5. Oxycodone 13.14.6. Tramadol 13.14.7. Other 13.15. Rest of Middle East & Africa Opioids Drugs Market Forecast, by Application 13.15.1. Anesthesia 13.15.2. Pain relief 13.15.3. Cough suppression 13.15.4. Diarrhea suppression 13.15.5. Deaddiction 13.16. Middle East & Africa Opioids Drugs Market Attractiveness Analysis 13.16.1. By Product 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Opioids Drugs Market Analysis 14.1. Key Findings 14.2. South America Opioids Drugs Market Overview 14.3. South America Opioids Drugs Market Value Share Analysis, by Product 14.4. South America Opioids Drugs Market Forecast, by Product 14.4.1. Buprenorphine 14.4.2. Fentanyl 14.4.3. Hydrocodone 14.4.4. Morphine 14.4.5. Oxycodone 14.4.6. Tramadol 14.4.7. Other 14.5. South America Opioids Drugs Market Value Share Analysis, by Application 14.6. South America Opioids Drugs Market Forecast, by Application 14.6.1. Anesthesia 14.6.2. Pain relief 14.6.3. Cough suppression 14.6.4. Diarrhea suppression 14.6.5. Deaddiction 14.7. South America Opioids Drugs Market Value Share Analysis, by Country 14.8. South America Opioids Drugs Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Opioids Drugs Market Analysis, by Country 14.10. Brazil Opioids Drugs Market Forecast, by Product 14.10.1. Buprenorphine 14.10.2. Fentanyl 14.10.3. Hydrocodone 14.10.4. Morphine 14.10.5. Oxycodone 14.10.6. Tramadol 14.10.7. Other 14.11. Brazil Opioids Drugs Market Forecast, by Application 14.11.1. Anesthesia 14.11.2. Pain relief 14.11.3. Cough suppression 14.11.4. Diarrhea suppression 14.11.5. Deaddiction 14.12. Mexico Opioids Drugs Market Forecast, by Product 14.12.1. Buprenorphine 14.12.2. Fentanyl 14.12.3. Hydrocodone 14.12.4. Morphine 14.12.5. Oxycodone 14.12.6. Tramadol 14.12.7. Other 14.13. Mexico Opioids Drugs Market Forecast, by Application 14.13.1. Anesthesia 14.13.2. Pain relief 14.13.3. Cough suppression 14.13.4. Diarrhea suppression 14.13.5. Deaddiction 14.14. Rest of South America Opioids Drugs Market Forecast, by Product 14.14.1. Buprenorphine 14.14.2. Fentanyl 14.14.3. Hydrocodone 14.14.4. Morphine 14.14.5. Oxycodone 14.14.6. Tramadol 14.14.7. Other 14.15. Rest of South America Opioids Drugs Market Forecast, by Application 14.15.1. Anesthesia 14.15.2. Pain relief 14.15.3. Cough suppression 14.15.4. Diarrhea suppression 14.15.5. Deaddiction 14.16. South America Opioids Drugs Market Attractiveness Analysis 14.16.1. By Product 14.16.2. By Application 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Acura Pharmaceuticals Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Manufacturing Footprint 15.3.2. Allergan Plc 15.3.3. Apotex Inc. 15.3.4. Assertio Therapeutics Inc. (Depomed Inc.) 15.3.5. Biodelivery Sciences International Inc. 15.3.6. Cipher Pharmaceuticals Inc. 15.3.7. Collegium Pharmaceutical Inc. 15.3.8. Daiichi Sankyo Inc. 15.3.9. Egalet Corp. 15.3.10. Endo International Plc 15.3.11. Hikma Pharmaceuticals Plc 15.3.12. Indivior Plc 15.3.13. Insys Therapeutics Inc. 15.3.14. Johnson & Johnson 15.3.15. Kempharm Inc. 15.3.16. Lannett Co. Inc. 15.3.17. Lupin Ltd. 15.3.18. Mallinckrodt 15.3.19. Mylan Nv 15.3.20. Orexo Ab 15.3.21. Pernix Therapeutics 15.3.22. Pfizer Inc. 15.3.23. Purdue Pharma Lp 15.3.24. Sun Pharmaceutical Industries Ltd. (Sun Pharma) 15.3.25. Teva Pharmaceutical Industries Ltd. 16. Primary Key Insights

About This Report

Report ID23754
Category Material & Chemical
Published Date
No of Pages235
Contact Us